Literature DB >> 8882745

An understanding of flow- and diffusion-limited vs. carrier-mediated hepatic transport: a simulation study.

W P Geng1, K Poon, K S Pang.   

Abstract

Concentration-dependent changes in the hepatic extraction ratio E and tissue accumulation of drugs were examined in a simulation study, wherein plasma protein binding, flow, and mode of entry were altered. A tubular flow model that described carrier-mediated (influx: Kml = 20 microM, Vmax1 = 1000 nmol min-1; efflux, Km2 = 200 microM, Vmax2 = 250 nmol min-1), flow-limited (influx clearance CLin = efflux clearance CLef = 50 ml min-1), or diffusion-limited (CLin = CLef = 0.1 ml min-1) hepatocytic entry was employed; drug removal was solely via biliary excretion (Km3 = 100 microM, Vmax3 = 1500 nmol min-1). Other parameter space and the combination of carrier-mediated transport and passive diffusion were also explored. Increased plasma protein binding reduced the hepatic extraction of the substrate, and in some instances, constituted the rate-controlling factor, especially at lower input concentrations for which tighter binding existed. Increased flow rate also brought about a reduction in E, affecting E almost inversely when values of E were low (e.g., for the diffusion-limited case or at higher input concentration). Tissue accumulation patterns and the apparent tissue distribution equilibrium ratio, i.e., tissue to plasma unbound concentration ratio Kp, differed among the systems. The behavior of Kp may be used as an identifier for the mode of drug transport: A declining (concave-down) Kp curve or a parabolic Kp that approached unity with input concentration (Cln) is associated with carrier-mediated entry; a rising Kp curve that approaches unity with Cln suggests flow limitation; and a waning concave-up Kp curve of very low magnitude represents diffusion limitation. Since the unbound tissue concentration (Ct) differs from the logarithmic average of the unbound input and output concentrations in plasma (Cu) for carrier-mediated and diffusion-limited systems, excretion parameters may be obtained only upon fitting of the overall excretion rate vs. Ct in the Michaelis-Menten equation; whereas when data are fitted with Cu, the rate-limiting step, influx, or deviations of influx, efflux, and excretion, will be obtained. When Ct equals Cu, as in flow-limited systems, accurate excretion parameters will be provided with the fitting of data against either Ct or Cu.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8882745     DOI: 10.1007/bf02353638

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  37 in total

1.  Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model.

Authors:  R A Weisiger; S Pond; L Bass
Journal:  Am J Physiol       Date:  1991-11

2.  Hepatic binding and Michaelis-Menten metabolism of drugs.

Authors:  G M Rubin; T N Tozer
Journal:  J Pharm Sci       Date:  1986-07       Impact factor: 3.534

3.  Effect of diffusional barriers on drug and metabolite kinetics.

Authors:  I A de Lannoy; K S Pang
Journal:  Drug Metab Dispos       Date:  1987 Jan-Feb       Impact factor: 3.922

4.  Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction.

Authors:  R H Smallwood; G W Mihaly; R A Smallwood; D J Morgan
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

5.  Prediction of drug distribution in distribution dialysis and in vivo from binding to tissues and blood.

Authors:  J Clausen; M H Bickel
Journal:  J Pharm Sci       Date:  1993-04       Impact factor: 3.534

6.  Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.

Authors:  Y Igari; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

7.  Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver.

Authors:  S Keiding; E Chiarantini
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

8.  Effect of protein binding on 4-methylumbelliferyl sulfate desulfation kinetics in perfused rat liver.

Authors:  M Chiba; K S Pang
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

9.  Prediction of drug distribution in vivo on the basis of in vitro binding data.

Authors:  G Schuhmann; B Fichtl; H Kurz
Journal:  Biopharm Drug Dispos       Date:  1987 Jan-Feb       Impact factor: 1.627

10.  Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver.

Authors:  I A de Lannoy; F Barker; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-08
View more
  2 in total

1.  Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method.

Authors:  A Hisaka; Y Sugiyama
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

2.  Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.

Authors:  Y Kwon; M E Morris
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.